Merck & Co., Inc. / Merck Sharp & Dohme Corp (MSD)
Industry / private company
Location:
Kenilworth, NJ,
United States (USA) (US)
ISNI: 0000000122600793
ROR: https://ror.org/02891sr49
Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease (2016)
Stitziel NO, Stirrups KE, Masca NGD, Erdmann J, Ferrario PG, Koenig IR, Weeke PE, et al.
Journal article
Preferences of German melanoma patients for interferon (IFN) ?-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy (2016)
Kaehler KC, Blome C, Forschner A, Gutzmer R, Haalck T, Heinzerling L, Kornek T, et al.
Journal article
Odanacatib treatment affects trabecular and cortical bone in the femur of postmenopausal women: results of a two-year placebo-controlled trial (2015)
Engelke K, Fuerst T, Dardzinski B, Kornak J, Ather S, Genant HK, De Papp A
Journal article
Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers (2014)
Reibis R, Voeller H, Gitt A, Jannowitz C, Halle M, Pittrow D, Hildemann S
Journal article
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength (2014)
Cheung AM, Majumdar S, Brixen K, Chapurlat R, Fuerst T, Engelke K, Dardzinski B, et al.
Journal article
Multispectral Opto-acoustic Tomography (MSOT) of the Brain and Glioblastoma Characterization (2013)
Burton NC, Patel M, Morscher S, Driessen WHP, Claussen J, Beziere N, Jetzfellner T, et al.
Journal article
Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia (2011)
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Van Kan GA, et al.
Journal article